Ligand Pharmaceuticals | 流动资产

股票价格
198.31
每天变化
2.14 1.09%
每月一次
4.25%
每年
62.24%
Q1 预测
192.24


金融业
股票价格
USD
资产
USD 1.56B
现金及等价物
USD 174.93M
销售成本
USD 11.9M
流动资产
USD 832.27M
流动负债
USD 37.45M
债务
USD 451M
EBIT
USD 158.89M
EBITDA
USD 150.32M
员工
68
EPS每股收益
USD 2.02
股本和储备
USD 1.02B
销售毛利
USD 155.28M
债务利息支出
USD 910K
利息收入
USD 3.87M
贷款资金
USD 445.49M
市值
USD 3.51B
净收入
USD 117.27M
营业费用
USD 8.29M
营业利润
USD 158.89M
普通股股本
USD 19.66M
PE价格收益
USD 60.65
税前利润
USD 141.14M
销售收入
USD 59.66M
销售和管理费用
USD 28.45M
股票
USD 9.13M
贸易债权人
USD 3.24M
应收帐款人
USD 58.1M


流动资产 更改 日
Agenus USD 133.95M 120.61M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Baxter International USD 6.87B 61M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Enviri Corporation USD 769.24M 21.36M 2025-09
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Glaxosmithkline GBP 23.98B 6.31B 2025-09
Heron Therapeutics USD 229.4M 18.48M 2025-09
Insmed USD 1.79B 137.6M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
MacroGenics USD 232.09M 27.15M 2025-09
Merck USD 47.56B 10.49B 2025-09
Pacira USD 547.97M 14.78M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 488.38M 39.15M 2025-12


Ligand Pharmaceuticals 流动资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.